Aruelo, Rochelle Mae V.
HRN: 16-31-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2022
CEFUROXIME 500MG (TAB)
11/27/2022
12/03/2022
ORAL
500mg
Q12Hrs
UTI; Covid-19 Pneumonia - Mild
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes